Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements - PubMed (original) (raw)
Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements
M Therrien et al. Mol Cell Biol. 1991 Jul.
Abstract
The pro-opiomelanocortin (POMC) gene is expressed very early during pituitary development, before expression of the other pituitary hormone genes, growth hormone and prolactin, and before expression of the Pit-1/GHF-1 transcription factor which activates those genes. Thus, analysis of the POMC promoter should provide markers of the early stages of pituitary development at the time when cells are being committed to expression of one or the other pituitary hormone. We have previously localized the rat POMC promoter to a 543-bp 5'-flanking DNA fragment of the gene using transfection and transgenic mice experiments. We have now used mutagenesis and in vitro protein-DNA binding studies to define three domains of the promoter which have distinct and complementary activities. Within these domains which require each other for full activity, at least nine regulatory elements were defined by in vitro footprinting and replacement mutagenesis. Each element appeared equally important for promoter activity, as mutagenesis of any element had similar effect on promoter activity. Most of the elements bound different AtT-20 nuclear proteins in gel mobility shift experiments. Whereas only two elements appeared to be binding sites for the known transcription factors AP-1 and chicken ovalbumin upstream promoter, the seven other elements appeared to bind nuclear proteins with novel properties. Thus, in contrast to the predominant role of Pit-1/GHF-1 in transcription of the growth hormone and prolactin genes, the control of an early pituitary gene, POMC, appears to depend on the synergistic interaction of several regulatory elements which bind different nuclear proteins.
Similar articles
- Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene.
Therrien M, Drouin J. Therrien M, et al. Mol Cell Biol. 1993 Apr;13(4):2342-53. doi: 10.1128/mcb.13.4.2342-2353.1993. Mol Cell Biol. 1993. PMID: 8455616 Free PMC article. - DNA elements with AT-rich core sequences direct pituitary cell-specific expression of the pro-opiomelanocortin gene in transgenic mice.
Liu B, Mortrud M, Low MJ. Liu B, et al. Biochem J. 1995 Dec 15;312 ( Pt 3)(Pt 3):827-32. doi: 10.1042/bj3120827. Biochem J. 1995. PMID: 8554527 Free PMC article. - A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy.
Bousquet C, Ray DW, Melmed S. Bousquet C, et al. J Biol Chem. 1997 Apr 18;272(16):10551-7. doi: 10.1074/jbc.272.16.10551. J Biol Chem. 1997. PMID: 9099700 - Tissue-specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucocorticoids.
Drouin J, Nemer M, Charron J, Gagner JP, Jeannotte L, Sun YL, Therrien M, Tremblay Y. Drouin J, et al. Genome. 1989;31(2):510-9. doi: 10.1139/g89-099. Genome. 1989. PMID: 2698828 Review. - Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids.
Drouin J, Charron J, Gagner JP, Jeannotte L, Nemer M, Plante RK, Wrange O. Drouin J, et al. J Cell Biochem. 1987 Dec;35(4):293-304. doi: 10.1002/jcb.240350404. J Cell Biochem. 1987. PMID: 3326882 Review.
Cited by
- Retinoic acid prevents experimental Cushing syndrome.
Páez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J, Grübler Y, Missale C, Arzt E, Stalla GK. Páez-Pereda M, et al. J Clin Invest. 2001 Oct;108(8):1123-31. doi: 10.1172/JCI11098. J Clin Invest. 2001. PMID: 11602619 Free PMC article. - Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells.
Parvin R, Noro E, Saito-Hakoda A, Shimada H, Suzuki S, Shimizu K, Miyachi H, Yokoyama A, Sugawara A. Parvin R, et al. PPAR Res. 2018 Apr 23;2018:5346272. doi: 10.1155/2018/5346272. eCollection 2018. PPAR Res. 2018. PMID: 29849538 Free PMC article. - Pituitary cell translation and secretory capacities are enhanced cell autonomously by the transcription factor Creb3l2.
Khetchoumian K, Balsalobre A, Mayran A, Christian H, Chénard V, St-Pierre J, Drouin J. Khetchoumian K, et al. Nat Commun. 2019 Sep 3;10(1):3960. doi: 10.1038/s41467-019-11894-3. Nat Commun. 2019. PMID: 31481663 Free PMC article. - The Ets factor Etv1 interacts with Tpit protein for pituitary pro-opiomelanocortin (POMC) gene transcription.
Budry L, Couture C, Balsalobre A, Drouin J. Budry L, et al. J Biol Chem. 2011 Jul 15;286(28):25387-96. doi: 10.1074/jbc.M110.202788. Epub 2011 May 26. J Biol Chem. 2011. PMID: 21622576 Free PMC article. - Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas.
Labeur M, Paez-Pereda M, Arzt E, Stalla GK. Labeur M, et al. Rev Endocr Metab Disord. 2009 Jun;10(2):103-9. doi: 10.1007/s11154-008-9080-6. Epub 2008 Jul 7. Rev Endocr Metab Disord. 2009. PMID: 18604646 Review.
References
- Anal Biochem. 1976 May 7;72:248-54 - PubMed
- Nucleic Acids Res. 1990 Aug 11;18(15):4513-21 - PubMed
- Nucleic Acids Res. 1978 Sep;5(9):3157-70 - PubMed
- Dev Biol. 1979 Feb;68(2):557-67 - PubMed
- Cell Tissue Res. 1979 Feb 28;196(3):409-27 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous